Who owns Cue Biopharma Inc?
- CUSIP Number: 22978p106
Tip: Access positions for across all investors
Analyze quarterly positions in Cue Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cue Biopharma stock
Who bought or sold Cue Biopharma Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Bleichroeder | 6.8M | $1.6M | 0% | Mar 2026 |
|
| Catalytic Wealth RIA | 4.6M | $1.1M | 0% | Mar 2026 |
|
| Vanguard Capital Management | 2.5M | $565k | 100% | Mar 2026 |
|
| Lion Point Capital | 2.2M | $506k | 0% | Mar 2026 |
|
| Geode Capital Management | 1.1M | $245k | 33% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 544k | $125k | 100% | Mar 2026 |
|
| Robertson Stephens Wealth Management | 479k | $110k | 0% | Mar 2026 |
|
| BlackRock | 449k | $103k | 0% | Mar 2026 |
|
| Texas Capital Bank Wealth Management Services | 397k | $91k | -10% | Mar 2026 |
|
| Angeles Wealth Management | 310k | $71k | 0% | Mar 2026 |
|
| Advisory Research | 257k | $59k | 0% | Mar 2026 |
|
| Stifel Financial | 247k | $57k | 0% | Mar 2026 |
|
| Renaissance Technologies | 214k | $49k | -10% | Mar 2026 |
|
| Bank of America Corporation | 208k | $48k | 100% | Mar 2026 |
|
| State Street Corporation | 179k | $41k | 0% | Mar 2026 |
|
| Diadema Partners | 132k | $30k | 100% | Mar 2026 |
|
| Northern Trust | 95k | $22k | -6% | Mar 2026 |
|
| UBS Group | 88k | $20k | 89% | Mar 2026 |
|
| Chicago Partners Investment | 86k | $50k | 0% | Mar 2026 |
|
| Northwestern Mutual Wealth Management Company | 80k | $18k | 0% | Mar 2026 |
|
| Advisortrust Partners | 50k | $12k | 100% | Mar 2026 |
|
| Virtu Financial | 50k | $11k | 100% | Mar 2026 |
|
| Sigma Planning | 39k | $8.9k | -6% | Mar 2026 |
|
| Goldman Sachs Group | 34k | $7.9k | 138% | Mar 2026 |
|
| Persistent Asset Partners | 33k | $7.7k | 100% | Mar 2026 |
|
| Visionary Wealth Advisors | 29k | $6.7k | 100% | Mar 2026 |
|
| Susquehanna International | 25k | $5.7k | -85% | Mar 2026 |
|
| GSA Capital Partners | 20k | $5.0k | 100% | Mar 2026 |
|
| Cambridge Investment Research Advisors | 20k | $5.0k | 0% | Mar 2026 |
|
| Goss Wealth Management | 20k | $4.6k | 0% | Mar 2026 |
|
| Prevail Innovative Wealth Advisors | 19k | $4.4k | 0% | Mar 2026 |
|
| Morgan Stanley | 18k | $4.2k | -1% | Mar 2026 |
|
| LPL Financial | 16k | $3.6k | -66% | Mar 2026 |
|
| XTX Topco | 15k | $3.5k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 13k | $3.0k | 100% | Mar 2026 |
|
| Citadel Advisors | 13k | $2.9k | 100% | Mar 2026 |
|
| Beacon Pointe Advisors | 10k | $2.3k | 100% | Mar 2026 |
|
| Barclays | 6.0k | $1.4k | 0% | Mar 2026 |
|
| Gleason Group | 6.0k | $1.4k | 0% | Mar 2026 |
|
| Newbridge Financial Services Group | 3.0k | $690.000000 | 0% | Mar 2026 |
|
| Wells Fargo & Company | 2.6k | $588.977400 | 0% | Mar 2026 |
|
| Dauntless Investment Group | 2.4k | $554.955200 | 100% | Mar 2026 |
|
| Golden State Wealth Management | 2.0k | $460.000000 | 0% | Mar 2026 |
|
| UMA Financial Services | 1.0k | $231.983600 | 0% | Mar 2026 |
|
| Mather Group | 1.0k | $230.000000 | 100% | Mar 2026 |
|
| Simplex Trading | 875.00 | $200.987500 | -66% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 415.00 | $94.993500 | 0% | Mar 2026 |
|
| Jones Financial Companies, L.L | 400.00 | $96.000000 | 0% | Mar 2026 |
|
| MAI Wealth Advisors | 350.00 | $80.990000 | 0% | Mar 2026 |
|
| Advisor Group Holdings | 300.00 | $69.000000 | -56% | Mar 2026 |
|
| Armstrong Advisory Group | 120.00 | $27.996000 | 0% | Mar 2026 |
|
| IFP Advisors | 100.00 | $23.000000 | 0% | Mar 2026 |
|
| Royal Bank of Canada | 75.00 | $0 | 100% | Mar 2026 |
|
Who sold out of Cue Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Boothbay Fund Management | Dec 2025 | 704k | $215k |
| Jane Street | Dec 2025 | 70k | $21k |
| Hrt Financial | Dec 2025 | 21k | $6.0k |
| HighTower Advisors | Dec 2025 | 11k | $3.3k |
| SeaCrest Wealth Management | Mar 2026 | 10k | $2.3k |
| Tidemark | Dec 2025 | 1.5k | $457.950000 |